COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04493099
Brief Title: Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML

First Submitted : July 27, 2020
First Submitted that Met QC Criteria : July 27, 2020
First Posted : July 30, 2020

Last Update Submitted that Met QC Criteria : November 9, 2020
Last Update Posted : November 12, 2020